LHEI
GILD icon

Leo H. Evart Inc’s Gilead Sciences GILD Stock Holding History

Leo H. Evart Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8K Buy
268
+1
+0.4% +$132 0.03% 127
2026
Q1 		$37.2K Buy
+267
New +$37.4K 0.03% 122

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Leo H. Evart Inc's GILD Position: Q2 2026 in Review

Leo H. Evart Inc increased its Gilead Sciences (GILD) stake by 0.37% in Q2 2026, buying an estimated $132 and bringing the position to 268 shares worth $33.8K. The position accounts for 0.03% of the portfolio, ranked #127.

Leo H. Evart Inc first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $37.2K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Leo H. Evart Inc held 268 shares of Gilead Sciences worth $33.8K as of Q2 2026.
  • Leo H. Evart Inc bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.03% of Leo H. Evart Inc's portfolio in Q2 2026, its #127 holding.
  • Leo H. Evart Inc first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Leo H. Evart Inc's Gilead Sciences position peaked at $37.2K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Leo H. Evart Inc's 13F filing for Q2 2026, filed 18 Aug 2026.